主な発表論文

Aihara T, Fujiwara Y, Ooka M, Sakita I, Tamaki Y, Monden M.

Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.

(Breast Cancer Res Treat.1999;58(2):137-40.)

Aihara T, Fujiwara Y, Miyake Y, Okami J, Okada Y, Iwao K, Sugita Y, Tomita N, Sakon M, Shiozaki H, Monden M.

Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.

(Cancer Lett.2000;150(1):79-84.)

Aihara T, Kim Y, Takatsuka Y.  

Phase II study of weekly docetaxel in patients with metastatic breast cancer.

(Ann Oncol.2002;13(2):286-92.)

Aihara T, Takatsuka Y, Itoh K, Sasaki Y, Katsumata N, Watanabe T, Noguchi S, Horikoshi N, Tabei T, Sonoo H, Hiraki S, Inaji H.

Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer.

(Oncology.2003;64(2):124-30.)

Aihara T, Takatsuka Y.

Dye-guided sentinel node biopsy revisited; validation and observational study from a single institute.

(Breast Cancer.2003;10(3):254-9.)

Aihara T, Munakata S, Morino H, Takatsuka Y.

Touch imprint cytology and immunohistochemistry for the assessment of sentinel lymph nodes in patients with breast cancer.

(Eur J Surg Oncol.2003 ;29(10):845-8.)

Aihara T, Munakata S, Morino H, Takatsuka Y.

Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study.

(J Surg Oncol.2004 ;85(2):77-81.)

Aihara T, Munakata S, Morino H, Takatsuka Y.

Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer.

(Ann Surg Oncol 2004;11(8):747-50.)

Aihara T, Takatsuka Y, Ohsumi S, Aogi, K, Hozumi Y, Imoto S, Mukai H, Iwata H, Watanabe T, Shimizu C, Nakagami K, Tamura M, Ito T, Masuda N, Ogino N, Hisamatsu K, Mitsuyama S, Abe H, Tanaka S, Yamaguchi T, Ohashi Y.

Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Japanese Postmenopausal Women with Hormone-Responsive Breast Cancer: N-SAS BC03 Study.

(Breast Cancer Research and Treatment 2010;121(2):379-87.)

Aihara T, Suemasu K, Takei H, Hozumi Y, Takehara M, Saito T, Ohsumi S, Masuda N, Ohashi Y.

Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients:results of N-SAS BC 04, the TEAM Japan substudy.

(Oncology.2010;79(5-6):376-81.)

Aihara T, Mukai H.

The current status and future perspectives of CSPOR-BC.

(Breast Cancer 2013;20(4):287-90.)

Aihara T, Tanaka S, Sagara Y, Iwata H, Hozumi Y, Takei H, Yamaguchi H, Ishitobi M, Egawa C.

Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapy.

(Breast Cancer 2014;21(3):284-91.)

Aihara T, Yokota I, Hozumi Y, Aogi K, Iwata H, Tamura M, Fukuuchi A, Makino H, Kim R, Andoh M, Tsugawa K, Ohno S, Yamaguchi T, Ohashi Y, Watanabe T, Takatsuka Y, Mukai H.

Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.

(Breast Cancer Res Treat.2014;148(2):337-43.)

Aihara T, Toyama T, Takahashi M, Yamamoto Y, Hara F, Akabane H, Fujisawa T, Ishikawa T, Nagai S, Nakamura R, Tsurutani J, Ito Y, Mukai H.

The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer, 2015 edition.

(Breast Cancer. 2016 ;23(3):329-42.)

Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S, Wada A.

Preoperative discrimination of fibroadenoma which is clinically and cytologically indistinguishable from breast carcinoma through clonal analysis of fine needle aspirate of tumor: Report of a case.

(Breast Cancer.1994;1(1):37-42.)

Noguchi S, Aihara T, Motomura K, Inaji H, Koyama H.

Clonal analysis of human breast tumors by means of polymerase chain reaction.

(Gan To Kagaku Ryoho.1994;21 Suppl 2:164-7(in Japanese).)

Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S.

Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis.

(Cancer .1994;74(3):872-7.)

Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H.

The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.

(Cancer.1994;74(5):1595-600.)

Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H, Tanaka H.

Demonstration of polyclonal origin of giant fibroadenoma of the breast.

(Virchows Arch.1995;427(3):343-7.)

Noguchi S, Yokouchi H, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H.

Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis.

(Cancer.1995;76(10):1779-85.)

Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S.

Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reaction.

(Cancer Lett 1995;90(1):57-63.)

Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H.

Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.

(Am J Pathol 1996;148(2):649-56.)

Noguchi S, Aihara T, Motomura K, Inaji H, Koyama H.

Detection of breast cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse-transcriptase polymerase chain reaction.

(Gan To Kagaku Ryoho.1996;23 Suppl 1:50-5(in Japanese).)

Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H, Kasugai T, Wada A.

Phyllodes Tumor of the Breast: Pathology, Histogenesis, Diagnosis, and Treatment.

(Breast Cancer.1996;3(2):79-92.)

Noguchi S, Aihara T, Yoshino K, Motomura K, Inaji H, Imaoka S, Koyama H.

Demonstration of monoclonal origin of human parotid gland pleomorphic adenoma.

(Cancer.1996;77(3):431-5.)

Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H.

Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.

(Cancer.1996;78(6):1235-40.)

Noguchi S, Hiratsuka M, Furukawa H, Aihara T, Kasugai T, Tamura S, Imaoka S, Koyama H, Iwanaga T.

Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction.

(Jpn J Cancer Res 1996;87(6):650-4.)

Munakata S, Aihara T, Morino H, Takatsuka Y.

Application of immunofluorescence for intraoperative evaluation of sentinel lymph nodes in patients with breast carcinoma.

(Cancer. 2003 ;98(8):1562-8.)

Taguchi T, Aihara T, Takatsuka Y, Shin E, Motomura K, Inaji H, Noguchi S.

Phase II study of weekly paclitaxel for docetaxel-resistant metastatic breast cancer in Japan.

(Breast J 2004;10(6):509-13.)

Hayakawa M, Aihara T, Takatsuka Y.

The marriage, pregnancy, childbirth on the breast cancer--psychologic care.

(Nippon Rinsho.2006;64(3):575-80(in Japanese). )

Ohsumi S, Shimozuma K, Ohashi Y, Shinji M, Hozumi Y, Mukai H, Takatsuka Y, Aihara T.

Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.

(Breast Cancer Res Treat 2011;127(1):143-52.)

Hozumi Y, Suemasu K, Takei H, Aihara T, Takehara M, Saito T, Ohsumi S, Masuda N, Ohashi Y.

The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.

(Ann Oncol.2011;22(8):1777-82.)

Oyama A, Ueno T, Uchiyama S, Aihara T, Miyake A, Kondo S, Matsunaga K.

The effects of natural S-equol supplementation on skin aging in postmenopausal women: a pilot randomized placebo-controlled trial.

(Menopause.2012;19(2):202-10.)

Miyake T, Aihara T, Noguchi S.

Diagnosis of metachronous bilateral breast cancer.

(Nihon Rinsho.2012;70 Suppl 7:284-7. (in Japanese))

Mukai H, Aihara T, Yamamoto Y, Takahashi M, Toyama T, Sagara Y, Yamaguchi H, Akabane H, Tsurutani J, Hara F, Fujisawa T, Yamamoto N, Ohsumi S.

The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.

(Breast Cancer. 2015;22(1):5-15.)

Kimura K, Iwamoto M, Tanaka S, Watanabe T, Aihara T, Sugimoto T, Miyara K, Hayashi M, Kouno T, Baba S, Kawashima H, Hashimoto N, Uchiyama K.

Is the LHRH Agonist Recommended for Fertility Preservation ?

(Gan To Kagaku Ryoho. 2015 ;42(8):1019-21. (in Japanese).)

Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thurlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

(Lancet. 2015;386(10001):1341-52.)

Hara F, Takashima T, Tsurutani J, Saito T, Taira N, Kashiwabara K, Aihara T, Mukai H.

Randomized, Optimal Dose Finding, Phase Ii Study of Tri-Weekly Nab-Paclitaxel in Patients with Metastatic Breast Cancer (ABROAD).

(J Clin Trials 2016, 6:3.)

Shimoi T, Shimomura A, Shien T, Uemura Y, Kato H, Kitada M, Toyama T, Aihara T, Mukai H.

Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial).

(Open Access Journal of Clinical Trials 2018:10 13-18)

Iwamoto T, Taira N, Fujisawa T, Araki K, Sakamaki K, Sangai T, Kikawa Y, Shien T, Takao S, Sato M, Goto Y, Yoshida T, Takahashi M, Aihara T, Mukai H.

Hormonal Therapy Resistant Estrogen-receptor Positive Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment Selection in Japan.

(Acta Med Okayama. 2018 Aug;72(4):369-374.)
産褥期の腫瘍性疾患への対応
相原智彦

ペリネイタルケア 2005年8月号
乳癌の術前化学療法
相原智彦、高塚雄一

医薬の門 2006年9月
詳細